Mark Austin - VP Finance/Prin Fin&Acct Offic at Perspective Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
VP Finance/Prin Fin&Acct Offic
Stock Symbol
CATX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Austin since 7/7/2023

Holdings reported by Mark Austin for Perspective Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common stock 84,030 $30.3 K $0.36 Apr 23, 2024 Direct
Stock option (right to buy) 120,000 Apr 23, 2024 Direct Common Stock

Transactions reported by Mark Austin for Perspective Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership